Merck, a life science leader, offers a comprehensive portfolio to support all stages of drug development and the manufacturing process. BioReliance® services – a global offering of exceptional, risk-mitigating approaches, testing, critical services and customized, complete solutions help bring life-changing therapies to market. Learn more at sigmaaldrich.com.

Merck BioDevelopment aims to support biotech companies transition from discovery to clinical and commercial development for biologics programs.
With more than 30 years' experience, around 260 biomolecules developed, we fully design and customize each program according to the project needs and client target.
Our goal is to provide a clear route to clinical trial material and commercial supply including cell line and process development, GMP batches manufacturing as well as process transfer and validation. We offer a CDMO business model for staging projects in line with data read-outs and/or financial milestones. : www.MerckMillipore.com/adaptive-CDMO